Eva Frei - Concepedia

Author

Eva Frei

German Cancer Research Center

Also Known As

E FREI, E Frei, E. FREI, E. Frei, E. III FREI, EVA FREI, Emil Frei, Eva Frei, Frei, Eva, Yunianto

282

Publications

6.7K

Citations

H-Index

102

Concepts

All Affiliations

German Cancer Research Center Heidelberg University Charles University King's College London National Center for Tumor Diseases

About

Eva Frei is an author at German Cancer Research Center specializing in medicine, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	79	2.8K
2	Biochemistry	30	69	2.4K
3	Natural Sciences	16	29	1K
4	Health Sciences	8	8	469
5	Engineering	2	2	27

Eva Frei

140

Publications

5.2K

Citations

H-Index

Page 1

	Year	Citations
Sudan I is a potential carcinogen for humans: evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes. Marie Stiborová, Václav Martínek, Helena Rýdlová, PubMed Metabolic ActivationPathologyToxicological MechanismToxicologyHepatotoxicity	2002	274
The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts☆ Marie Stiborová, Christian A. Bieler, Eva Frei Biochemical Pharmacology Molecular PharmacologyMedicinal ChemistryBiochemistryNatural SciencesMedicine	2001	148
Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice Volker M. Arlt, Marie Stiborová, Colin J. Henderson, Carcinogenesis	2007	142
The Anticancer Drug Ellipticine Forms Covalent DNA Adducts, Mediated by Human Cytochromes P450, through Metabolism to 13-Hydroxyellipticine and Ellipticine<b><i>N</i></b>2-Oxide Marie Stiborová, Jan Sejbal, Lucie Bořek-Dohalská, Cancer Research	2004	133
Environmental Pollutant and Potent Mutagen 3-Nitrobenzanthrone Forms DNA Adducts after Reduction by NAD(P)H:Quinone Oxidoreductase and Conjugation by Acetyltransferases and Sulfotransferases in Human Hepatic Cytosols Volker M. Arlt, Marie Stiborová, Colin J. Henderson, Cancer Research	2005	121
Human Enzymes Involved in the Metabolic Activation of Carcinogenic Aristolochic Acids: Evidence for Reductive Activation by Cytochromes P450 1A1 and 1A2 Marie Stiborová, Eva Frei, Heinz H. Schmeiser Chemical Research in Toxicology	2001	120
Albumin binding ligands and albumin conjugate uptake by cancer cells Eva Frei Diabetology & Metabolic Syndrome	2011	100
Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:Cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid‐DNA adducts found in patients with urothelial cancer Marie Stiborová, Eva Frei, Petr Hodek, International Journal of Cancer	2004	96
Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium Shamik Das, Aniruddha Banerji, Eva Frei, Life Sciences FibrosisSerum Free MediumBreast OncologyMedicineCell-matrix Interaction	2007	92
Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by <sup>32</sup>P-postlabelling analysis using different chromatographic procedures Marie Stiborová, R.Charles Fernando, Heinz H. Schmeiser, Carcinogenesis Medicinal ChemistryNucleic Acid ChemistryBiochemistryNatural SciencesMedicine	1994	92

Page 1